{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T09:45:12Z","timestamp":1774863912420,"version":"3.50.1"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018778","name":"Al-Azhar University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018778","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bioorg.2026.109718","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:10:04Z","timestamp":1772583004000},"page":"109718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Investigations on isatin-pyrimidinone hybrids as novel lead compounds for selective inhibition of TrkA enzyme"],"prefix":"10.1016","volume":"174","author":[{"given":"Basma S.","family":"Abdulrazik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samy","family":"Mohamady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walaa R.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amgad","family":"Albohy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109718_bb0005","first-page":"48","article-title":"Cancer \u2013 an overview","volume":"40","author":"Krieghoff-Henning","year":"2017","journal-title":"Med. Monatsschr. Pharm."},{"key":"10.1016\/j.bioorg.2026.109718_bb0010","series-title":"Global cancer Burden Growing, Amidst Mounting Need for Services","author":"Geneva","year":"2024"},{"key":"10.1016\/j.bioorg.2026.109718_bb0015","series-title":"Cancer Facts & Figures 2024","author":"American Cancer Society","year":"2024"},{"key":"10.1016\/j.bioorg.2026.109718_bb0020","first-page":"594","article-title":"Mg-based materials diminish tumor spreading and cancer metastases","volume":"19","author":"Globig","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioorg.2026.109718_bb0025","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","article-title":"Metastasis","volume":"186","author":"Gerstberger","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.109718_bb0030","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1073\/pnas.92.12.5258","article-title":"The causes and prevention of cancer","volume":"92","author":"Ames","year":"1995","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2026.109718_bb0035","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1158\/0008-5472.CAN-07-6611","article-title":"A history of Cancer chemotherapy","volume":"68","author":"DeVita","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.109718_bb0040","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4103\/0019-509X.200658","article-title":"Cancer and cure: a critical analysis","volume":"53","author":"Roy","year":"2016","journal-title":"Indian J. Cancer"},{"key":"10.1016\/j.bioorg.2026.109718_bb0045","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1634\/theoncologist.2010-0354","article-title":"Chemotherapy-related hospitalization among community Cancer center patients","volume":"16","author":"Hassett","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.bioorg.2026.109718_bb0050","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4236\/jct.2014.58089","article-title":"Side effects of chemotherapy in Cancer patients and evaluation of patients opinion about starvation based differential chemotherapy","volume":"05","author":"Aslam","year":"2014","journal-title":"J. Cancer Ther."},{"key":"10.1016\/j.bioorg.2026.109718_bb0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","article-title":"The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (review)","volume":"40","author":"Ardito","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bioorg.2026.109718_bb0060","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra013339","article-title":"Imatinib Mesylate \u2014 a new Oral targeted therapy","volume":"346","author":"Savage","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.109718_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115618","article-title":"Recent advances in the discovery of tropomyosin receptor kinases TRKs inhibitors: a mini review","volume":"258","author":"El-Nassan","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114901","article-title":"Design, development and evaluation of a prodrug-type TrkA-selective inhibitor with antinociceptive effects in vivo","volume":"245","author":"Tang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117608","article-title":"Design, synthesis and evaluate of indazolylaminoquinazoline derivatives as potent tropomyosin receptor kinase (TRK) inhibitors","volume":"99","author":"Xu","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0080","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev.biochem.72.121801.161629","article-title":"Trk receptors: roles in neuronal signal transduction","volume":"72","author":"Huang","year":"2003","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3835(01)00530-4","article-title":"Trk receptor tyrosine kinases: a bridge between cancer and neural development","volume":"169","author":"Nakagawara","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2026.109718_bb0090","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrclinonc.2017.127","article-title":"Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance","volume":"14","author":"Schram","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.109718_bb0095","first-page":"1807","article-title":"A novel modular mosaic of cell adhesion motifs in the extracellular domains of the neurogenic trk and trkB tyrosine kinase receptors","volume":"6","author":"Schneider","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2026.109718_bb0100","series-title":"Vitamins and Hormones","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.vh.2016.10.001","article-title":"Crystal Structures of Neurotrophin Receptors Kinase Domain","volume":"(104).","author":"Bertrand","year":"2017"},{"key":"10.1016\/j.bioorg.2026.109718_bb0105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jmb.2012.08.002","article-title":"The crystal structures of TrkA and TrkB suggest key regions for achieving selective inhibition","volume":"423","author":"Bertrand","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2026.109718_bb0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neuron.2006.09.034","article-title":"Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors","volume":"53","author":"Wehrman","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.bioorg.2026.109718_bb0115","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1749-6632.1995.tb26693.x","article-title":"Structural and functional properties of the TRK family of neurotrophin receptors","volume":"766","author":"Barbacid","year":"1995","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.bioorg.2026.109718_bb0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1074\/jbc.RA119.011312","article-title":"Structural basis of the transmembrane domain dimerization and rotation in the activation mechanism of the TRKA receptor by nerve growth factor","volume":"295","author":"Franco","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0125","series-title":"STRUCTURE AND ORGANIZATION OF THE HUMAN TRKA GENE Encoding a High Affinity Receptor for Nerve Growth Factor","author":"Indo","year":"1997"},{"key":"10.1016\/j.bioorg.2026.109718_bb0130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jmgm.2018.01.004","article-title":"Ligand-based computer aided drug design reveals new tropomycin receptor kinase a (TrkA) inhibitors","volume":"80","author":"Shahin","year":"2018","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.bioorg.2026.109718_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114899","article-title":"Switch type I to type II TRK inhibitors for combating clinical resistance induced by xDFG mutation for cancer therapy","volume":"245","author":"Xiang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0140","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.37765\/ajmc.2022.88845","article-title":"Comparative effectiveness of larotrectinib and entrectinib for TRK fusion cancer","volume":"28","year":"2022","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.bioorg.2026.109718_bb0145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1158\/2159-8290.CD-20-0571","article-title":"TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors","volume":"11","author":"Cocco","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2026.109718_bb0150","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK fusion-positive cancers and TRK inhibitor therapy","volume":"15","author":"Cocco","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.109718_bb0155","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1158\/2159-8290.CD-18-0484","article-title":"Repotrectinib (TPX-0005) is a next-generation ROS1\/TRK\/ALK inhibitor that potently inhibits ROS1\/TRK\/ALK solvent- front mutations","volume":"8","author":"Drilon","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2026.109718_bb0160","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1158\/2159-8290.CD-17-0507","article-title":"A next-generation TRK kinase inhibitor overcomes acquired resistance to prior TRK kinase inhibition in patients with TRK fusion\u2013positive solid tumors","volume":"7","author":"Drilon","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2026.109718_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128900","article-title":"Isatin containing heterocycles for different biological activities: analysis of structure activity relationship","volume":"1222","author":"Nath","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109718_bb0170","article-title":"Synthesis, in vivo anti-inflammatory activity, and molecular docking studies of new isatin derivatives","volume":"2016","author":"Jarapula","year":"2016","journal-title":"Int. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0175","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jphotobiol.2018.04.029","article-title":"Isatin based macrocyclic Schiff base ligands as novel candidates for antimicrobial and antioxidant drug design: in vitro DNA binding and biological studies","volume":"183","author":"Bharathi Dileepan","year":"2018","journal-title":"J. Photochem. Photobiol. B."},{"key":"10.1016\/j.bioorg.2026.109718_bb0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/1568026053386944","article-title":"New anticonvulsant agents","volume":"5","author":"Malawska","year":"2005","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0185","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/14756366.2016.1238366","article-title":"Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase","volume":"32","author":"Meleddu","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12039-020-01795-0","article-title":"Design and synthesis of novel isatin derivatives as potent analgesic, anti-inflammatory and antimicrobial agents","volume":"132","author":"Lahari","year":"2020","journal-title":"J. Chem. Sci."},{"key":"10.1016\/j.bioorg.2026.109718_bb0195","first-page":"1","article-title":"Isatin Derivatives with Several Biological Activities","volume":"6","author":"Grewal","year":"2014","journal-title":"International Journal of Pharmaceutical Research"},{"key":"10.1016\/j.bioorg.2026.109718_bb0200","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejmech.2009.12.035","article-title":"New isatin derivatives with antioxidant activity","volume":"45","author":"Andreani","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0205","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/oxfordjournals.aje.a121057","article-title":"Prophylaxis of smallpox with methisazone1","volume":"90","author":"Bauer","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.bioorg.2026.109718_bb0210","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/S0040-4020(01)96609-8","article-title":"The structure and properties of some indolic constituents in Couroupita guianensis aubl","volume":"41","author":"Bergman","year":"1985","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2026.109718_bb0215","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01169241","article-title":"Synthesis of heterocyclic compounds by the cyclization of isatin and its derivatives (review)","volume":"32","author":"Shvekhgeimer","year":"1996","journal-title":"Chem Heterocycl Compd"},{"key":"10.1016\/j.bioorg.2026.109718_bb0220","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s11094-017-1616-1","article-title":"Assessment of 5-substituted Isatin as surface recognition group: design, synthesis, and Antiproliferative evaluation of Hydroxamates as novel histone deacetylase inhibitors","volume":"51","author":"Singh","year":"2017","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.bioorg.2026.109718_bb0225","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-0032-1333306","article-title":"Synthesis, and docking studies of some fused-quinazolines and Quinazolines carrying biological active Isatin moiety as cell-cycle inhibitors of breast cancer cell lines","volume":"63","author":"Radwan","year":"2013","journal-title":"Drug Res."},{"key":"10.1016\/j.bioorg.2026.109718_bb0230","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.1016\/j.tet.2012.06.049","article-title":"Synthesis and anti-leukaemic activity of pyrrolo[3,2,1-hi]indole-1,2-diones, pyrrolo[3,2,1-Ij]quinoline-1,2-diones and other polycyclic isatin derivatives","volume":"68","author":"Matesic","year":"2012","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2026.109718_bb0235","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1016\/j.bmc.2011.08.044","article-title":"Synthesis and biological evaluation of a novel class of isatin analogs as dual inhibitors of tubulin polymerization and Akt pathway","volume":"19","author":"Krishnegowda","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0240","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/ph15030272","article-title":"Therapeutic outcomes of Isatin and its derivatives against multiple diseases: recent developments in drug discovery","volume":"15","author":"Cheke","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.109718_bb0245","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1734-1140(13)71007-7","article-title":"Biochemical and pharmacological characterization of isatin and its derivatives: from structure to activity","volume":"65","author":"Pakravan","year":"2013","journal-title":"Pharmacol. Rep."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109718_bb0250","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2174\/156802606777812077","article-title":"Recent advances in the research and development of RAF kinase inhibitors","volume":"6","author":"Smith","year":"2006","journal-title":"Curr Top Med Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0255","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1039\/C8SC02634C","article-title":"Machine intelligence decrypts \u03b2-lapachone as an allosteric 5-lipoxygenase inhibitor","volume":"9","author":"Rodrigues","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2026.109718_bb0260","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.bmcl.2003.12.002","article-title":"Discovery and in vitro evaluation of potent TrkA kinase inhibitors: oxindole and aza-oxindoles","volume":"14","author":"Wood","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109718_bb0265","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1016\/j.bmcl.2006.04.020","article-title":"Synthesis and antibacterial evaluation of ureides of Baylis\u2013Hillman derivatives","volume":"16","author":"Nag","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109718_bb0270","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ejmech.2014.10.061","article-title":"4-Aminoquinoline-pyrimidine hybrids: synthesis, antimalarial activity, heme binding and docking studies","volume":"89","author":"Kumar","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0275","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1021\/jm9811256","article-title":"Structure\u2212antiviral activity relationship in the series of pyrimidine and purine N -[2-(2-Phosphonomethoxy)ethyl] nucleotide analogues. 1. Derivatives substituted at the carbon atoms of the base","volume":"42","author":"Hol\u00fd","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0280","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.1021\/jo00052a057","article-title":"Synthesis of various 3\u2032-branched 2\u2032,3\u2032-unsaturated pyrimidine nucleosides as potential anti-HIV agents","volume":"57","author":"Czernecki","year":"1992","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0285","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1016\/j.bmcl.2014.05.002","article-title":"Studies on molecular properties prediction, antitubercular and antimicrobial activities of novel quinoline based pyrimidine motifs","volume":"24","author":"Desai","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109718_bb0290","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2302\/kjm.2013-0003-RE","article-title":"Purinergic Signalling: pathophysiology and therapeutic potential","volume":"62","author":"Burnstock","year":"2013","journal-title":"Keio J. Med."},{"key":"10.1016\/j.bioorg.2026.109718_bb0295","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bioorg.2018.01.028","article-title":"Novel pyrimidine-pyridine hybrids: synthesis, cyclooxygenase inhibition, anti-inflammatory activity and ulcerogenic liability","volume":"77","author":"Abdelgawad","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103127","article-title":"Utilization of tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidinone as a cap moiety in design of novel histone deacetylase inhibitors","volume":"91","author":"Mohamed","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0305","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1080\/16583655.2018.1510163","article-title":"Synthesis and studies molecular docking of some new thioxobenzo[g]pteridine derivatives and 1,4-dihydroquinoxaline derivatives with glycosidic moiety","volume":"12","author":"Ghoneim","year":"2018","journal-title":"J. Taibah Univ. Sci."},{"key":"10.1016\/j.bioorg.2026.109718_bb0310","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1134\/S1070363223080194","article-title":"Recent advances on Pyrazole-pyrimidine\/fused pyrimidine hybrids with anticancer potential (a review)","volume":"93","author":"Wang","year":"2023","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114654","article-title":"Discovery of 3-pyrazolyl-substituted pyrazolo[1,5-a]pyrimidine derivatives as potent TRK inhibitors to overcome clinically acquired resistance","volume":"241","author":"Gong","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27154912","article-title":"Pyrimidines-based heterocyclic compounds: synthesis, Cytoxicity evaluation and molecular docking","volume":"27","author":"El-Atawy","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109718_bb0325","article-title":"Pharmacophore-linked pyrazolo[3,4-d]pyrimidines as EGFR-TK inhibitors: synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies","author":"Gaber","year":"2021","journal-title":"Arch. Pharm. (Weinheim)."},{"key":"10.1016\/j.bioorg.2026.109718_bb0330","doi-asserted-by":"crossref","DOI":"10.1186\/s13065-024-01166-7","article-title":"Synthesis, anticancer evaluation, molecular docking and ADME study of novel pyrido[4\u2032,3\u2032,3,4]pyrazolo[1,5-a]pyrimidines as potential tropomyosin receptor kinase a (TrKA) inhibitors","volume":"18","author":"Metwally","year":"2024","journal-title":"BMC Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0335","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1016\/j.bmc.2018.10.004","article-title":"Novel 5,6-disubstituted pyrrolo[2,3-d]pyrimidine derivatives as broad spectrum antiproliferative agents: synthesis, cell based assays, kinase profile and molecular docking study","volume":"26","author":"Lee","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0340","doi-asserted-by":"crossref","first-page":"22106","DOI":"10.1039\/C4RA01689K","article-title":"A convenient synthesis of pyrimidinone and pyrimidine containing bisheteroarenes and analogs","volume":"4","author":"Maurya","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.109718_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106591","article-title":"Isatin-pyrimidine hybrid derivatives as enoyl acyl carrier protein reductase (InhA) inhibitors against mycobacterium tuberculosis","volume":"138","author":"Khalifa","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0350","series-title":"Organic Reactions","first-page":"1","article-title":"The Biginelli Dihydropyrimidine Synthesis","author":"Kappe","year":"2004"},{"key":"10.1016\/j.bioorg.2026.109718_bb0355","doi-asserted-by":"crossref","first-page":"6937","DOI":"10.1016\/S0040-4020(01)87971-0","article-title":"100 years of the biginelli dihydropyrimidine synthesis","volume":"49","author":"Oliver Kappe","year":"1993","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2026.109718_bb0360","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1016\/j.tetlet.2016.09.047","article-title":"Biginelli reaction: an overview","volume":"57","author":"Nagarajaiah","year":"2016","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2026.109718_bb0365","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-1979-28650","article-title":"A one-step synthesis of 4-Oxo-2-thioxopyrimidine derivatives by the ternary condensation of ethyl Cyanoacetate, aldehydes, and Thiourea","volume":"1979","author":"Kambe","year":"1979","journal-title":"Synthesis (Stuttg.)"},{"key":"10.1016\/j.bioorg.2026.109718_bb0370","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/14756366.2022.2051022","article-title":"Pyrimidine-5-carbonitrile based potential anticancer agents as apoptosis inducers through PI3K\/AKT axis inhibition in leukaemia K562","volume":"37","author":"El-Dydamony","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0375","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s00044-014-1188-5","article-title":"Synthesis, 3D-QSAR and docking studies of pyrimidine nitrile-pyrazoline: a novel class of hybrid antimalarial agents","volume":"24","author":"Marella","year":"2015","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.109718_bb0380","doi-asserted-by":"crossref","first-page":"15831","DOI":"10.1002\/anie.201508746","article-title":"Synthesis of carbazole alkaloids by ring-closing metathesis and ring rearrangement\u2013aromatization","volume":"54","author":"Dhara","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2026.109718_bb0385","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1021\/acs.joc.8b03194","article-title":"\u201cOn water\u201d direct Organocatalytic Cyanoarylmethylation of Isatins for the Diastereoselective synthesis of 3-Hydroxy-3-cyanomethyl Oxindoles","volume":"84","author":"Zhang","year":"2019","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2019.130916","article-title":"The selective condensation of pyrazolones to isatins in aqueous medium","volume":"76","author":"Zhang","year":"2020","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2026.109718_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.tetlet.2020.152109","article-title":"Reductive aromatization of oxindoles to 3-substituted indoles","volume":"61","author":"Mandal","year":"2020","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2026.109718_bb0400","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.3390\/molecules28124882","article-title":"Evaluation of anti-Neuroinflammatory activity of Isatin derivatives in activated microglia","volume":"28","author":"Cenalmor","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109718_bb0405","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1039\/c5pp00275c","article-title":"Isatin phenylhydrazones: anion enhanced photochromic behaviour","volume":"14","author":"Cig\u00e1\u0148","year":"2015","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.bioorg.2026.109718_bb0410","doi-asserted-by":"crossref","DOI":"10.1002\/ejoc.202400439","article-title":"Palladium-catalyzed isocyanide insertion into the remotely activated N\u2212H bond of 3-(phenylhydrazono)oxindoles: facile access to indole- N -carboxamide derivatives","volume":"27","author":"Soam","year":"2024","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0415","doi-asserted-by":"crossref","first-page":"10651","DOI":"10.1002\/slct.202102290","article-title":"A new strategy for the preparation of E isomers of Hydrazones and Anil-like compounds: thermally stimulated isomerization of Z isomers of anions","volume":"6","author":"Tisovsk\u00fd","year":"2021","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.109718_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25133082","article-title":"Effect of a =X-NH-fragment, (X = C, N), on Z\/E isomerization and ON\/OFF functionality of Isatin Arylhydrazones, ((Arylamino)methylene)Indolin-2-ones and their anions","volume":"25","author":"Tisovsk\u00fd","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109718_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104366","article-title":"Design and synthesis of novel isatin-based derivatives targeting cell cycle checkpoint pathways as potential anticancer agents","volume":"105","author":"Yousef","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0430","author":"Konstantinovi\u0107"},{"key":"10.1016\/j.bioorg.2026.109718_bb0435","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ejmech.2017.06.060","article-title":"Leucine rich repeat kinase 2 (LRRK2) inhibitors based on indolinone scaffold: potential pro-neurogenic agents","volume":"138","author":"Salado","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0440","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/poc.3164","article-title":"Self-association, tautomerism and E\u2013Z isomerization of isatin\u2013phenylsemicarbazones \u2013 spectral study and theoretical calculations","volume":"26","author":"Jakusov\u00e1","year":"2013","journal-title":"J. Phys. Org. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotochem.2020.112916","article-title":"Tautomerization of Z and E isomers of dipolar isatin bipyridylhydrazone complexes with Zn(II) ions. Photochromism - ON\/OFF switching","volume":"405","author":"Tisovsk\u00fd","year":"2021","journal-title":"J. Photochem. Photobiol. A Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0450","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.3390\/curroncol29110640","article-title":"Expression and signaling pathways of nerve growth factor (NGF) and pro-NGF in breast Cancer: a systematic review","volume":"29","author":"Bruno","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bioorg.2026.109718_bb0455","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/onc.2009.61","article-title":"TrkA overexpression enhances growth and metastasis of breast cancer cells","volume":"28","author":"Lagadec","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2026.109718_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom10091329","article-title":"The receptor tyrosine kinase trka is increased and targetable in HER2-positive breast cancer","volume":"10","author":"Griffin","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2026.109718_bb0465","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbrc.2011.01.116","article-title":"DNA methylation-dependent regulation of TrkA, TrkB, and TrkC genes in human hepatocellular carcinoma","volume":"406","author":"Jin","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2026.109718_bb0470","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.11927","article-title":"Nerve growth factor regulates liver cancer cell polarity and motility","volume":"23","author":"Lin","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bioorg.2026.109718_bb0475","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1038\/sj.leu.2404882","article-title":"Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, \u0394TrkA","volume":"21","author":"Meyer","year":"2007","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.bioorg.2026.109718_bb0480","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00001756-199703240-00001","article-title":"Induction of TrkA receptor by retinoic acid in leukaemia cell lines","volume":"8","author":"Xie","year":"1997","journal-title":"Neuroreport"},{"issue":"6","key":"10.1016\/j.bioorg.2026.109718_bb0485","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood.V83.6.1479.1479","article-title":"Expression and functionality of the trkA proto-oncogene product\/NGF receptor in undifferentiated hematopoietic cells","volume":"83","author":"Chevalier","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2026.109718_bb0490","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.2147\/OTT.S177051","article-title":"Antitumor activity of larotrectinib in tumors harboring NTRK gene fusions: a short review on the current evidence","volume":"12","author":"Ricciuti","year":"2019","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.bioorg.2026.109718_bb0495","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/1521-1878(200009)22:9<818::AID-BIES7>3.0.CO;2-6","article-title":"Integrating the MAP kinase signal into the G1 phase cell cycle machinery","volume":"22","author":"Roovers","year":"2000","journal-title":"BioEssays"},{"issue":"5205","key":"10.1016\/j.bioorg.2026.109718_bb0500","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1126\/science.7892601","article-title":"Tyrosine kinase inhibition: an approach to drug development","volume":"267","author":"Levitzki","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2026.109718_bb0505","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.3390\/molecules30173630","article-title":"Comparative analysis of biochemical and cellular assay conditions and the need for a buffer that mimics cytoplasmic environments","volume":"30","author":"Kontopidis","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109718_bb0510","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1701848114","article-title":"Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery","volume":"114","author":"Mateus","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2026.109718_bb0515","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejmech.2019.04.053","article-title":"Targeting tropomyosin receptor kinase for cancer therapy","volume":"175","author":"Miao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109718_bb0520","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.cdd.4400213","article-title":"Downregulation of Bcr-Abl in K562 cells restores susceptibility to apoptosis: characterization of the apoptotic death","volume":"4","author":"McGahon","year":"1997","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bioorg.2026.109718_bb0525","doi-asserted-by":"crossref","first-page":"W32","DOI":"10.1093\/nar\/gku293","article-title":"SwissTargetPrediction: a web server for target prediction of bioactive small molecules","volume":"42","author":"Gfeller","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.109718_bb0530","doi-asserted-by":"crossref","first-page":"W26","DOI":"10.1093\/nar\/gku477","article-title":"SuperPred: update on drug classification and target prediction","volume":"42","author":"Nickel","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.109718_bb0535","article-title":"DockRMSD: an open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism","volume":"11","author":"Bell","year":"2019","journal-title":"J. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0540","doi-asserted-by":"crossref","unstructured":"K. Stierand, P.C. Maa\u00df, M. Rarey, Molecular complexes at a glance: automated generation of two-dimensional complex diagrams, in: Bioinformatics, Oxford University Press, 2006: pp. 1710\u20131716. doi:https:\/\/doi.org\/10.1093\/bioinformatics\/btl150.","DOI":"10.1093\/bioinformatics\/btl150"},{"key":"10.1016\/j.bioorg.2026.109718_bb0545","first-page":"82","article-title":"Pymol: an open-source molecular graphics tool","volume":"40","author":"DeLano","year":"2002","journal-title":"CCP4 Newsl. Protein Crystallogr."},{"key":"10.1016\/j.bioorg.2026.109718_bb0550","doi-asserted-by":"crossref","DOI":"10.36877\/pddbs.a0000424","article-title":"Illustrated procedure to perform molecular docking using PyRx and biovia discovery studio visualizer: a case study of 10kt with atropine","volume":"6","author":"Ayodele","year":"2023","journal-title":"Prog. Drug Discov. Biomed. Sci."},{"key":"10.1016\/j.bioorg.2026.109718_bb0555","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109718_bb0560","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.4155\/bio-2021-0132","article-title":"Cytochrome P450 enzymes: a review on drug metabolizing enzyme inhibition studies in drug discovery and development","volume":"13","author":"Rao Gajula","year":"2021","journal-title":"Bioanalysis"},{"key":"10.1016\/j.bioorg.2026.109718_bb0565","series-title":"Synthesis and Preliminary Antimicrobial Evaluation of Schiff Bases of N-Benzyl Isatin Derivatives","author":"Shakir","year":"2020"},{"key":"10.1016\/j.bioorg.2026.109718_bb0570","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1080\/14756366.2022.2104841","article-title":"Discovery of novel thiazolyl-pyrazolines as dual EGFR and VEGFR-2 inhibitors endowed with in vitro antitumor activity towards non-small lung cancer","volume":"37","author":"Abdelsalam","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0575","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1080\/10406638.2021.1998146","article-title":"Microwave-assisted one-pot three component synthesis of some Thiazolyl(Hydrazonoethyl)Thiazoles as potential anti-breast Cancer agents","volume":"42","author":"Mahmoud","year":"2022","journal-title":"Polycycl. Aromat. Compd."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2026.109718_bb0580","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"Journal of Immunological Methods"},{"key":"10.1016\/j.bioorg.2026.109718_bb0585","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1080\/14756366.2017.1421181","article-title":"Novel [(3-indolylmethylene)hydrazono]indolin-2-ones as apoptotic anti-proliferative agents: design, synthesis and in vitro biological evaluation","volume":"33","author":"Eldehna","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0590","doi-asserted-by":"crossref","first-page":"D1083","DOI":"10.1093\/nar\/gkt1031","article-title":"The ChEMBL bioactivity database: an update","volume":"42","author":"Bento","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.109718_bb0595","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/ci3001277","article-title":"ZINC: a free tool to discover chemistry for biology","volume":"52","author":"Irwin","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.109718_bb0600","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10787-019-00637-x","article-title":"In vivo antiulcer activity, phytochemical exploration, and molecular modelling of the polyphenolic-rich fraction of Crepis sancta extract","volume":"28","author":"Ebada","year":"2020","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bioorg.2026.109718_bb0605","doi-asserted-by":"crossref","first-page":"38128","DOI":"10.1039\/D0RA04876C","article-title":"Anti-inflammatory, antiallergic and COVID-19 protease inhibitory activities of phytochemicals from the Jordanian hawksbeard: identification, structure\u2013activity relationships, molecular modeling and impact on its folk medicinal uses","volume":"10","author":"Ebada","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.109718_bb0610","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0615","doi-asserted-by":"crossref","unstructured":"S. Dallakyan, A.J. Olson, Small-Molecule Library Screening by Docking with PyRx, 2015, pp. 243\u2013250, doi: https:\/\/doi.org\/10.1007\/978-1-4939-2269-7_19.","DOI":"10.1007\/978-1-4939-2269-7_19"},{"key":"10.1016\/j.bioorg.2026.109718_bb0620","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1021\/ci049794h","article-title":"Personal experience with four kinds of chemical structure drawing software: review on ChemDraw, ChemWindow, ISIS\/draw, and ChemSketch","volume":"44","author":"Li","year":"2004","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.bioorg.2026.109718_bb0625","first-page":"17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J. Chem."},{"key":"10.1016\/j.bioorg.2026.109718_bb0630","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/ci100031x","article-title":"Conformer generation with OMEGA: algorithm and validation using high quality structures from the protein databank and Cambridge structural database","volume":"50","author":"Hawkins","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.109718_bb0635","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1298","article-title":"Using PyMOL as a platform for computational drug design","volume":"7","author":"Yuan","year":"2017","journal-title":"WIREs Comput. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.109718_bb0640","series-title":"VIDA: an environment for multidimensional image display and analysis","first-page":"694","author":"Hoffman","year":"1992"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:45:09Z","timestamp":1774860309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826002543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":128,"alternative-id":["S0045206826002543"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109718","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigations on isatin-pyrimidinone hybrids as novel lead compounds for selective inhibition of TrkA enzyme","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109718","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109718"}}